The objective was to perform a systematic review in order to describe the relation ship between asthma and sleepdisordered breathing (SDB) in children, especially regarding the impact of treatment and management. Methods: We performed an electronic search in MEDLINE, EMBASE, and LILACS database. Study inclusion criteria were the following: 1) studies that examined the relationship between asthma/wheezing and SDB/obstructive sleep apnea (OSA); and 2) studies conducted in children ,18 years of age. Primary outcomes were the prevalence of asthma and SDB, the tests used for diagnosis, and the influence of their treatment and management. Results: One thousand and twenty studies were identified, among which 32 were selected (n=143,343 children; 51% males; age [mean ± standard deviation] 8.4±2.5 years). Most studies (n=26) diagnosed SDB using questionnaires or clinical history. Nine studies performed a sleep study for diagnosing OSA. The diagnosis of asthma was based on clinical history (n=16), previ ous medical diagnosis (n=4), questionnaires (n=12), and spirometry (n=5). Children with asthma were more likely to develop habitual snoring and OSA, and children with SDB were more likely to develop asthma. Moreover, asthma was associated with more severe OSA, and the presence of SDB was associated with severe asthma. Treatment of SDB with adenotonsillectomy was associated with significant asthma improvement.
Introduction
Asthma is known to be one of the most common chronic diseases in childhood. 1 is habitual snoring (ie, snoring in more than three nights weekly). Similar to asthma, symptoms of SDB may remain unrecognized for a long time. 8 Treatment of SDB, for example, adenotonsillectomy (AT), often resolves snoring and concomitant symptoms. However, a large multicenter study in asthmatic children 9 showed that SDB may persist even after AT.
Furthermore, asthma and SDB may coexist, as they are both inflammatory diseases of the lower and upper airway tract, respectively. 10 Similar symptoms during the night may also lead to confusion in clinical history. The similarities and parallel rise of prevalence of both diseases in the last decades arise the question that if there is a relationship between asthma and SDB. 11 Therefore, we launched the present systematic review, in order to describe the relationship between asthma and SDB, especially regarding the impact of treatment and management of these diseases.
Methods

Search and selection criteria
We identified all published studies in MEDLINE, EMBASE, and LILACS (up to November 2015) database, using follow ing keywords: "(asthma OR wheezing) AND (sleep) AND (obstructive sleep apnea OR sleep disordered breathing) AND (children OR child OR adolescent)". Studies published solely in abstract form were excluded because methods and results could not be fully analyzed. To be included, studies had to meet all the following criteria: case-control, cohort, or intervention studies that examined the relationship between asthma/wheezing and SDB/OSA in subjects aged ,18 years of age; and all kinds of treatments were accepted (especially AT, considered the firstline treatment for SDB). No language restriction for the studies was applied. We excluded studies in which participants had any other chronic underlying disease such as craniofacial abnormalities, neurological disorders, dysmorphic genetic disorders or metabolic disorders, or other chronic respiratory illness different from asthma/wheezing. All references were managed by reference manager software (Mendeley ® 1.14; Elsevier Inc, Philadelphia, PA, USA).
Target conditions
Childhood asthma was accepted as a clinical diagnosis (ie, "chronic inflammatory disease of the lower respiratory tract with recurrent or persistent wheezing"). 3 Most of the studies usually diagnosed asthma by questionnaire. On the other hand, SDB was defined according to the International Classification of Sleep Disordersthird edition 12 (ie, habitual snoring, upper airway resistance syndrome, and OSA). It was accepted that SDB diagnosis was made clinically or through questionnaire or polysomnography (PSG). Our primary outcomes were 1) prevalence of asthma and SDB (using different tests for their diagnoses), 2) asthma as a risk factor for SDB and vice versa, and 3) the influence of their management.
Data extraction and assessment of risk of bias
Titles, abstracts, and citations were independently analyzed by two authors (TS and PEB). Based on the fulltext form, all studies were evaluated for inclusion/exclusion criteria, type of intervention, population included, study design, and outcomes. After obtaining full reports about potentially relevant trials, eligibility was assessed. Disagreements were discussed and resolved by consensus.
Results
Studies description
In total, 1,020 (n) studies were identified. Among those, 32 (N) studies 9,10,13-42 met the inclusion criteria ( Figure 1 ). The studies included a total of 143,343 children (51.3% were males) of age (mean ± standard deviation) 8.4±2.5 years. Fourteen studies came from USA, 9, 22, 24, 25, 29, 31, [34] [35] [36] [38] [39] [40] [41] [42] nine from Asia, 13, 14, 18, 20, 28, 30, 32, 33, 37 seven from Europe, 10, [15] [16] [17] 19, 23, 26 Records identified through database searching (n=1,020)
Full-text articles assessed for eligibility (n=84)
Full-text articles excluded (n=53)
Studies included (n=32)
Reasons: -Data extraction not possible (n=18) -Letters, editorials, reviews, case reports (n=8) -Publication on the same cohort (n=3) -Subjects aged >18 years of age (n=24) 
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and two from Oceania. 21, 27 Almost all studies diagnosed SDB using questionnaires (ie, the Pediatric Sleep Ques tionnaire [PSQ]), 18, 29, 32, 33 clinical history, 10, [13] [14] [15] [16] [17] [19] [20] [21] [22] [23] [26] [27] [28] 35 or previous medical diagnosis. 36, 38, 39, 42 Eight studies performed PSG, 9, 24, 30, 31, 34, 37, 40, 41 and only one, a home cardiorespira tory polygraphy. 25 On the other hand, the diagnosis of asthma was based on clinical history exclusively in 16 studies, 9, 10, 15, 17, 19, [23] [24] [25] [26] [30] [31] [32] 35, 39, 40, 42 previous medical asthma diagnosis in four studies, 20, 29, 36, 38 general questionnaires in six studies, 14, 15, 17, 18, 21, 33 and the International Study of Asthma and Allergies in Childhood 43 questionnaire in six studies. 13, 16, 22, 27, 28, 34 Only five studies performed spirometry for assessing asthma. 16, 22, 25, 34, 41 Studies on association and/or risk of SDB in asthmatics Table 1 shows the studies that investigated the association between asthma and SDB. 9, 10, 16, 21, 24, 25, [27] [28] [29] [30] [31] [32] 34, 35, 37 The aim of eleven studies was to describe the prevalence and risk factors of SDB, among which we were able to find data on asthma. [13] [14] [15] 17, 18, 20, 22, 26, 33, 40, 41 Table 2 gives the result of them. Overall, the studies showed that children with asthma/ wheeze were more likely to have a higher risk for habitual snoring and OSA than those without asthma. For example, a study in Belgian children 28 reported that wheezing was related to an increased risk of snoring (odds ratio [OR] =2.8, 95% CI 1.1-2.6). A study on Austrian children 27 showed a strong and significant association between SDB symptoms and wheeze/asthma, especially between snoring (OR =5.4, 95% CI 3.6-8.1) and snorting (OR =5.3, 95% CI 2.6-10.8) with wheezing in the last 12 months. In another study, chil dren with wheezing had a significantly higher prevalence of snoring, and more nocturnal awakenings than nonwheezing children (46% vs 26% and 30% vs 20%, respectively); after multiple logistic regression analysis, wheeze remained as a risk factor for difficulties falling asleep (OR =2.0, 95% CI 1.0-4.0), restless sleep (OR =5.0, 95% CI 2.2-11.1), day time sleepiness (OR =3.8, 95% CI 1.8-8.0), and tiredness (OR =5.1, 95% CI 2.2-12.1). 16 Asthma was also associated with tonsillar hypertrophy. In a prospective cohort of 442 Greek children who consulted the emergency department (ED) and pulmonology clinic, history of wheezing was significantly associated with the presence of tonsillar hypertrophy and snoring (OR =2.36, 95% CI 1.46-3.79 and OR =1.88, 95% CI 1.24-2.86, respectively). 10 When questionnaires (eg, PSQ) were used, 29 the prevalence of a positive test (.0.33) was significantly higher in asthmatic children than in non asthmatic children (25.9% vs 10.6%, P,0.001, respectively; OR =2.94, 95% CI 1.82-4.75). Interestingly, the effect of asthma was "dose dependent", as children with more severe asthma had increased OR for snoring and a positive PSQ.
Studies using PSG to determine SDB showed similar results. A study in 50 AfricanAmerican children 34 con cluded that poorly controlled asthma was associated with more severe OSA; a history of lifetime asthma increased the apnea-hypopnea index (AHI) by 8.8 (P,0.005) in the PSG. A study 24 that investigated parameters of sleep fragmentation by PSG concluded that asthmatic snorer's children had worse sleep quality as judged by indices of sleep fragmentation than those without asthma. Moreover, a study of OSA diag nosed by PSG in a sleep center in the USA 31 reported that maximal %SpO 2 rapideyemovement (REM) desaturation, REM-obstructive AHI, and prevalence of REMrelated OSA were significantly increased in asthmatic children with OSA compared to subjects with only OSA, showing that asthma is associated with REMrelated breathing abnormalities in children with moderate-severe OSA. A crosssectional study 37 that investigated sleep quality by PSG in children aged 6-12 years found that asthmatics had significantly longer sleep latency and less slowwave sleep compared with non asthmatics; also, asthmatics (either with or without OSA) had significantly more leg movement than nonasthmatics. This study supports the hypothesis that nonobese asthmatic children, with or without OSA, may exhibit poor sleep quality as compared with nonobese nonasthmatic children. There is a known seasonal variability described in SDB. 44 In our studies, asthma and atopy did not explain this variation. Greenfeld et al 30 in a review on 2,178 PSG of children and adolescents referred for suspected SDB, with a prevalence of asthma of 18%, found that the mean obstructive AHI in the winter was significantly higher compared to the summer (9.1±9.6 vs 7.5±7.0, P=0.01; Cohen d=0. 19) , particularly in children younger than the age of 5 years (10.2±10.5 vs 7.9±7.3, P=0.008; Cohen d=0. 25) , and asthma/atopy had no significant effect on seasonal variability.
In contrast to the studies described, only one study showed that a history of asthma decreased the likelihood of OSA. 24 That was a retrospective review of patients referred to a sleep laboratory for an overnight PSG, and it compared the definition of OSA as an AHI .2 or .5. No significant differences in OSA prevalence or severity for asthmatics compared to nonasthmatics were found. The authors of that study explained these findings due to a possible referral bias; since parents of asthmatics would be more vigilant regarding nighttime symptoms, they may have mistaken night noises 
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(asthma symptoms and noisy breathing) for snoring, having an "over"report of night symptoms.
Studies on association and/or risk of asthma in children with SDB
Children with SDB were more likely to develop asthma/ wheeze than those without asthma/wheeze. Lu et al 21 reported that 42.2% of children who snored had asthma (OR =2.03, 95% CI 1.34-3.10). There was also a highly significant asso ciation between snoring and nocturnal cough (OR =3.68, 95% CI 2.41-5.63). In that study, nocturnal cough was strongly associated with asthma; in the asthmatic group, the prevalence of nocturnal cough was significantly higher among children who snored vs children who did not snore (86.1% vs 52.6%, respectively, P=0.001; OR =5.56, 95% CI 2.26-13.67). Sulit et al 25 in a US communitybased cohort study of 788 participants (aged 8-11 years) found that children with SDB had nearly twice the odds of wheeze compared with those without SDB (OR =1.89, 95% CI 1.26-2.85). Recently, a large Chinese epidemiological study 32 (n=20,672 children, mean age 9.0±1.61 years) concluded that habitual snoring and OSA remained a statistically significant predictor of asthma (OR =1.28, 95% CI 1.01-1.62 and OR =1.92, 95% CI 1.34-2.76, respectively). In a prospective study on 108 asthmatic patients (mean age 9.1±3.4 years), children with SDB had more than three times the risk for having severe asthma at followup (OR =3.62, 95% CI 1.26-10.4). 35 Only three studies that analyzed risk factors for asthma development investigated SDB. 19, 23, 36 Those results are given in the following. In the study of Hoskyns et al, 19 the relation ship between night cough and other indices of asthma severity was studied in 21 children with clinically stable asthma and 23 Finally, a retrospective cohort study 36 of asthmatic children (n=25,900) who required hospitalization showed a higher risk of hospital length of stay .2 days (OR =2.3, 95% CI 1.8-2.9) for those with previous diagnosis of OSA (1.4% of the group) than those without OSA. The authors of that study suggested that children with OSA and asthma experience a higher severity of nocturnal hypoxemia and hypoventilation; therefore, it may possibly take longer time to return to an acceptable respiratory status after an asthma crisis. 40 conducted a prospective study on 92 poorly controlled asthma children (aged 3-10 years) with a mean frequency of acute asthmatic exacerbations of 3.4±0.4/year. Overnight PSG revealed the presence of OSA (AHI .5/hour of total sleep time) in 63.0% of patients (OR =40.9, 95% CI 12.9-144.1) compared to the maximal estimated prevalence of OSA in a nonasthmatic population. From this group, information at 1year follow up was available for 35 asthmatics with OSA after AT, and for 24 without OSA. The annual frequency of acute asth matic exacerbations in the postAT subgroup significantly decreased (from 4.1±1.3 to 1.8±1.4/year, P,0.0001), with no changes in the nonOSA group. Similar favorable improve ment occurred after AT in the frequency of βagonist rescue use or in asthma symptom scores. Busino et al 39 reviewed retrospectively 560 children who underwent AT; 16,6% were asthmatics, 97.8% of this group underwent AT for OSA. AT was associated with significant reductions in asthma thera pies, including corticosteroids, and with improvements in asthma control test scores.
Studies on therapy
Discussion
In this systematic review of 32 studies, we found a mean prevalence of asthma of 33.2%, and of SDB 41.8%. Asthma is estimated to affect 7.1 million US children under the age of 18 years. 1 The prevalence of asthma in children varies through different countries. In the studies we reviewed, the asthma prevalence ranged from 8.8% in Belgium 16 to 28% in Australia. 21 On the other hand, the prevalence of snoring is estimated to be 3.2%-12.1%, and the prevalence of OSA ranges from 0.7% to 10.3%. 45 When parents were asked about habitual snoring (usually three or four times per week), the prevalence reported in the studies of this systematic review was 6% in a group of Singapore children, 14 7% in Turkey, 17 10.1% in Germany, 26 12% in the People's Republic of China, 20, 21, 32, 33 14.6% in Australia, 22 and 28% in Belgium. 16 When standard ized questionnaires were used (eg, the PSQ), the prevalence of SDB symptoms was 14.9% in Malaysia. 18 However, PSG is known to be the gold standard for SDB but has important limitations due to availability and cost. This may explain the reason why only a few studies in our systematic review used it for SDB and OSA diagnosis. Redline et al 41 
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prevalence of SDB in a general population of children in the USA to be 1.6% and 10.3% by using a PSG diagnostic criteria of AHI .10 and 5, respectively. In order to discuss the current evidence of an association between SDB/OSA and asthma, it is important to mention the definitions of sleeprelated breathing disorders. Childhood SDB is a spectrum of abnormal breathing patterns during sleep that ranges from primary snoring to OSA. OSA in children is an SDB characterized by prolonged partial upper airway obstruction and/or intermittent complete obstruction that affects normal ventilation during sleep. 46 OSA is con sidered the most severe disease within the spectrum of SDB. It is associated with symptoms including habitual snoring, sleep difficulties, and daytime neurobehavioral problems and has the potential to result in serious longterm consequences, such as cognitive deficits, academic failure, cardiovascular complications, and metabolic syndrome.
There is a growing body of evidence of an association between SDB and asthma, supported by most of the studies described in our review. Our previous systematic review on prevalence of asthma and SDB including 17 studies involv ing 45,155 children found that children with asthma had a significantly higher risk of SDB (OR =1.9, 95% CI 1.2-2.2). 47 However, the relationship between asthma and SDB appears bidirectional. SDB, especially OSA, may exacerbate asthma by altering oropharyngeal reflexes and increasing negative intrathoracic pressure, increasing cholinergic tone, and promoting bronchoconstriction.
14 Studies like the one by Pescatore et al reinforce that SDB may even predict asthma development. 23 In addition, a large retrospective cohort showed that SDB may even prolong the recovery of children after hospitalization due to asthma. 36 On the other hand, we found many studies showing that asthma may exacerbate SDB disrupting sleep, resulting in sleep deprivation and increasing the frequency of apneas in snorers.
14 Also, poorly controlled asthma might accentuate the hypoxemia in SDB and vice versa; intermittent nocturnal hypoxemia in children with OSA could initiate and maintain upper and lower airway inflammation. 48, 49 Therefore, this bidirectional association may be explained due to common risk factors that promote airway inflamma tion, sharing a common pathogenetic pathway. This is referred as the "oneairway" hypothesis, suggesting that upper airway inflammation and intermittent hypoxia from obstruction may influence the expression and severity of disease of the lower respiratory tract. 50, 51 Lower and upper airway inflammation is related to atopy and incremented cysteinyl leukotriene activity, and can lead to decreased lower airway caliber and increased nasal resistance and pharyngeal collapsibility, [52] [53] [54] predisposing to wheeze and snore during sleep. Also, adeno tonsillar hypertrophy increases upper airway resistance and is the first cause of SDB in children. It seems that asthma is associated with tonsillar hypertrophy, 10 and children with history of wheezing have larger tonsils than subjects without wheezing. Hypertrophic tonsils could mediate at least in part the known association between asthma and obstructive SDB in childhood. This is reinforced by two studies, 55, 56 demonstrating that increased cysteinyl leukotrienes activity is present in tonsils excised from children with OSA, seeming to promote tonsillar cell proliferation.
In addition to what we already knew concerning the pos sible relationship of asthma and SDB, 49 we aimed to analyze in the present systematic review how treatment impacts on both diseases. We found several studies addressing how SDB treatment impacts on asthma. However, no studies were found so far that compared how asthma treatment impacts on SDB.
The firstline treatment for OSA in children is AT (if the patient has demonstrated adenotonsillar hypertrophy and does not have contraindications to surgery). 15, 46 In the past years, there has been increasing interest in studying the effect of AT, as firstline SDB/OSA treatment, and improvement of childhood asthma. [38] [39] [40] KheirandishGozal et al 40 demonstrated that the annual frequency of acute asthmatic exacerbations in children postAT decreased significantly compared to those without AT. Based on this interesting study, one may hypoth esize that upper airway inflammatory processes may play a role in lower airway inflammation and asthma, and conversely, lower airway inflammatory disease may promote adenoton sillar proliferation, and therefore increase the propensity for OSA. 40 Therefore, treatment of OSA may benefit control of asthma. In a study of Bhattacharjee et al 38 on 13,506 children with asthma, only 6.2% of those who underwent AT and 0.6% of those who did not undergo the surgical procedure had some form of evaluation for SDB as determined by searching for specific sleep diagnostic testing. This finding shows that most patients are operated without having a sleep diagnosis, even if they are scheduled for a surgical procedure. Considering that asthmatics might have a higher prevalence and severity of OSA, a formal sleep study should be considered case by case, especially before surgical procedures. In another multicenter study by Bhattacharjee et al 9 (n=578 children), the presence of asthma was a significant factor for persisting with OSA after AT, and the study underlined the importance of a postAT PSG in children with asthma undergoing AT. A longitudinal observational study 42 on 130 children (aged 2-18 years), both with and without asthma, undergoing AT showed that asthma control test scores and chitinase activity 
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in the circulation (biomarkers of airway inflammation, such as upper airway and asthmatic disease) measured at time of sur gery and at 6month followup had a significant improvement. A significant improvement in asthma control test scores after 6 months and decrease in several asthmarelated outcomes (eg, rate of ED visits, oral corticosteroid courses, missed school days due to asthma, and total missed parental work days) and in circulating chitinase activity (median decrease 0.4 nmol/L/ mL/h, P,0.01) suggest that AT also may modulate airway inflammation in asthma. These studies support the idea that detection and treatment of adenotonsillar tissue hypertrophy may serve as an important strategy for improving asthma control. However, randomized controlled studies are needed to confirm this.
There are certainly other treatment for OSA (ie, nasal corticosteroids sprays 57, 58 and LTRAs). 59 Dental devices or oral appliance therapy, surgical procedures, and continuous positive airway pressure may be considered as secondline treatment. Most of them have specific indications for patients with specific chronic diseases (eg, neuromuscular disorders). We did not find eligible studies of these treatments in patients with asthma and SDB.
The present study, as usual in this kind of systematic reviews, has limitations that need to be addressed. We made the highest effort in finding most available studies on the topic. However, there are some interesting studies that might have escaped our search strategy. Prevalence of asthma and SDB was originally calculated only in some studies; we recalcu lated it from the data of several other included studies. Hence, this may have biased this outcome, as some studies were not intended as epidemiologic studies for prevalence estimation. In most included studies, asthma and SDB were among a long list of factors analyzed, but only few studies aimed to analyze specifically the relationship between them. Hence, a data extrac tion bias is also possible. Future studies specifically designed for demonstrating the bidirectional relationship between both diseases may help to confirm our results. As mentioned earlier, only studies that analyzed AT as treatment for SDB were found. Therefore, we do not know if other therapeutic options for SDB, for example, nasal corticosteroids, LTRAs, or maxillary interventions, may have some influence on asthma.
Conclusion
The present systematic review shows that asthma and SDB are both very frequent conditions in childhood, and may have a bidirectional relationship. Treatment of SDB seems to impact positively on the clinical evolution of asthma in children. It is yet to be proven whether or not optimizing asthma control could prevent consequences of SDB.
